Clustering Insights
The Life Sciences podcast series featuring key players in the industry. Hear opinions and thought leadership from investors, developers, funders and more.
Latest episode
The importance of early-stage VC funding
In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Jason Mellad, Co-Founder & CEO of Startcodon. This episode looks at the opportunities for scaling Life Sciences businesses to gain venture capital backing and the opportunities across the UK to bridge the gap between start-ups and value-add investors.
Our recommendations
Propelling future growth in Life Sciences - with Pete Wilder, Oxford Sciences Innovation (OSI)
Delivering development, investment and regeneration - with Rachel Dickie, Legal & General Capital
Influencing design and engineering in life sciences - with Matthew Jones, Hoare Lea
Connecting clusters of space, energy tech, quantum and sciences at Harwell - with Stuart Grant and Barbara Ghinelli
Missed an episode? Catch up here
The societal impact of the life science sector – placing ESG at the heart of investment decisions - with John O’Driscoll from AXA Investment Managers – Real Assets
Growing Need for GMP Manufacturing - with Kasia Averall, Head of Clusters at Cell and Gene Therapy Catapult
Addressing the issues of supply and demand in life sciences - with Neelam Patel, Chief Executive Officer at MedCity
Growing Need for GMP Manufacturing - with Kasia Averall, Head of Clusters at Cell and Gene Therapy Catapult
Lessons learned from the US life sciences market - with Travis McCready and Dr Glenn Crocker, JLL
A new way of building a lab - an overview of SmartLabs in the US - with Amrit Chaudhuri
Delivering development, investment and regeneration - with Rachel Dickie, Legal & General Capital
Propelling future growth in Life Sciences - with Pete Wilder, Oxford Sciences Innovation (OSI)
Lessons learned from the US life sciences market - with Travis McCready and Dr Glenn Crocker, JLL
The importance of destination locations for innovation in life sciences - with Tony Jones from One Nucleus
Growing Need for GMP Manufacturing - with Kasia Averall, Head of Clusters at Cell and Gene Therapy Catapult
Retaining the UK as a centre for innovation - with Harriet Fear MBE, Managing Director at Cambridge&.
Connecting clusters of space, energy tech, quantum and sciences at Harwell - with Stuart Grant and Barbara Ghinelli
Influencing design and engineering in life sciences - with Matthew Jones, Hoare Lea
Accommodating Life Science occupiers in London and beyond - with Charles Walford, Development Director & Head of Life Sciences, Stanhope
A new way of building a lab - an overview of SmartLabs in the US - with Amrit Chaudhuri
Putting company growth and employee experience at the heart of real estate decisions - with Michael Skynner and Richard Hughes from Bicycle Therapeutics
Speaker biographies
-
Jason Mellad
CEO & Co-Founder, Start Codon
Jason is a scientist entrepreneur passionate about translating innovative technologies into better patient outcomes. As CEO and co-founder of Start Codon, a Cambridge based venture builder, he aims to identify the most disruptive healthcare founders and innovations worldwide, seed fund them and leverage the exceptional resources of the Cambridge cluster to de-risk and drive the success of their start-ups.
-
Harriet Fear
Managing Director
Harriet was a Diplomat for over 20 years with the British Foreign Office. She served in 17 countries, in various roles including Deputy Ambassador 3 times, Head of Press and Public Affairs and Head of Commercial Services. Harriet has worked at the heart of the Cambridge business ecosystem since 2003. She was awarded an MBE in 2016 for her services to Healthcare and Life Sciences. Harriet is currently leading Cambridge&, the shop window for innovation/inward investment service for Greater Cambridge and is Chair of Cambridge Ahead and founder of HFA Ltd.
-
Kasia Averall
Head of Clusters, Cell & Gene Therapy Catapult
Kasia Averall is Head of Cluster Development at the Cell and Gene Therapy Catapult. She is responsible for shaping and delivering a strategic UK cell and gene therapy manufacturing cluster working with a variety of organisations to de-risk and speed up the establishment of approved cell and gene therapy manufacturing facilities.
Talk to us about life sciences
Find out how smart location, space and facility management decisions can help fuel your scientific breakthroughs.
PRIVACY NOTICE
Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.
Generally the personal information we collect from you are for the purposes of dealing with your enquiry.
We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.